Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.

Authors
Category Systematic review
JournalSurgical oncology
Year 2012
This review examines the clinical efficacy and safety of the use of hepatic arterial chemoembolization, bland embolization and radioembolization in the treatment of unresectable neuroendocrine tumor liver metastases (NETLM). Response to treatment, survival outcome and toxicity were examined in this review of 37 studies comprising 1575 patients. These therapies are safe and effective in the treatment of NETLM. Prospective clinical trials to compare the relative efficacy and toxicity are warranted.
Epistemonikos ID: 5cba2c8abdc1cfeab06d9205768a5e9597531112
First added on: Feb 11, 2013